AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
14 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
13 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
10 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
09 Sep 2010 11:30 AM
RNS
Director/PDMR Shareholding
09 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
08 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
07 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
06 Sep 2010 04:30 PM
RNS
Director/PDMR Shareholding
06 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
03 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
02 Sep 2010 04:30 PM
RNS
Director/PDMR Shareholding
02 Sep 2010 07:00 AM
RNS
Seroquel XR gets EC approval
02 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
01 Sep 2010 06:00 PM
RNS
Director/PDMR Shareholding
01 Sep 2010 04:30 PM
RNS
Total Voting Rights
01 Sep 2010 07:00 AM
RNS
Transaction in Own Shares
31 Aug 2010 04:30 PM
RNS
Director/PDMR Shareholding
31 Aug 2010 07:00 AM
RNS
CRL received from FDA for mot
31 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
27 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
26 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
25 Aug 2010 04:30 PM
RNS
Director/PDMR Shareholding
25 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
24 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
23 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
20 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
19 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
18 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
17 Aug 2010 04:30 PM
RNS
Director/PDMR Shareholding
17 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
16 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
13 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
12 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
11 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
10 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
09 Aug 2010 07:00 AM
RNS
Seroquel Product Liability Li
06 Aug 2010 04:30 PM
RNS
Share Repurchase Programme
06 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
05 Aug 2010 04:00 PM
RNS
Holding(s) in Company
05 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
04 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
03 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
02 Aug 2010 04:30 PM
RNS
Total Voting Rights
02 Aug 2010 07:00 AM
RNS
Transaction in Own Shares
30 Jul 2010 04:30 PM
RNS
Director/PDMR Shareholding
29 Jul 2010 02:00 PM
RNS
Directorate Change
29 Jul 2010 07:00 AM
RNS
Second Quarter and Half Year
29 Jul 2010 07:00 AM
RNS
Second Quarter and Half Year
29 Jul 2010 07:00 AM
RNS
Second Quarter and Half Year
29 Jul 2010 07:00 AM
RNS
FDA AdCom votes for approval
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100